期刊
STEM CELLS TRANSLATIONAL MEDICINE
卷 10, 期 4, 页码 522-533出版社
OXFORD UNIV PRESS
DOI: 10.1002/sctm.20-0351
关键词
neural crest stem cells (NCSCs); development; cancer; melanoma; tumor initiation; invasion; drug resistance
Melanoma is a deadly skin cancer with high metastatic potential, and advances in targeted therapy and immunotherapy have improved treatment. However, drug resistance remains a major obstacle. The progression of melanoma is associated with cellular dedifferentiation and gene regulatory networks, requiring novel approaches to combat stemness characteristics.
Melanoma is the deadliest of all skin cancers due to its high metastatic potential. In recent years, advances in targeted therapy and immunotherapy have contributed to a remarkable progress in the treatment of metastatic disease. However, intrinsic or acquired resistance to such therapies remains a major obstacle in melanoma treatment. Melanoma disease progression, beginning from tumor initiation and growth to acquisition of invasive phenotypes and metastatic spread and acquisition of treatment resistance, has been associated with cellular dedifferentiation and the hijacking of gene regulatory networks reminiscent of the neural crest (NC)-the developmental structure which gives rise to melanocytes and hence melanoma. This review summarizes the experimental evidence for the involvement of NC stem cell (NCSC)-like cell states during melanoma progression and addresses novel approaches to combat the emergence of stemness characteristics that have shown to be linked with aggressive disease outcome and drug resistance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据